Stock Comparison

JNJ vs TWST

Johnson & Johnson vs Twist Bioscience Corp

The Verdict

TWST takes this one.

JNJ

Johnson & Johnson

1.0

out of 10

Distressed

Winner

TWST

Twist Bioscience Corp

7.0

out of 10

Solid Pick

Head-to-Head

$557.1B

Market Cap

$4.2B

26.5

P/E Ratio

14.7

21.8%

Profit Margin

-19.9%

26.3%

Return on Equity

-17.5%

0.6

Debt-to-Equity

0.5

Conservative

Overall Risk

Aggressive

1.0

DVR Score

7.0

The Deep Dive

JNJ1.0/10

Johnson & Johnson (JNJ) continues to demonstrate robust financial performance, with Q1 2026 results exceeding consensus on both revenue and adjusted EPS, reflecting nearly 10% YoY revenue growth. Its diversified healthcare portfolio provides significant market leadership and a wide economic moat, indicating stability and consistent profitability. However, its massive market capitalization of $555....

Full JNJ Analysis

TWST7.0/10

Twist Bioscience maintains its high-risk, high-reward profile with compelling 10x growth potential, driven by its unique silicon-based DNA synthesis platform and strategic entry into DNA data storage. Q2 FY26 results confirmed strong revenue growth and expanded clonal gene offerings, reinforcing its market opportunity and technological moat. However, the reported EPS miss for Q2 FY26 and ongoing i...

Full TWST Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.